MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ISCO had -$60K decrease in cash & cash equivalents over the period. $98K in free cash flow.

Cash Flow Overview

Change in Cash
-$60K
Free Cash flow
$98K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Accrued liabilities
    • Accounts payable
    • Non-cash operating lease expense
    • Others
Negative Cash Flow Breakdown
    • Inventories
    • Payments on related party note p...
    • Prepaid expenses and other curre...
    • Others

Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Product sales
2,315 9,100 --
Cost of sales
954 4,033 --
General and administrative
1,122 3,532 --
Selling and marketing
273 1,118 --
Research and development
156 684 --
Total operating expenses
2,505 9,367 --
Loss from operations
-190 -267 --
Total other expense, net
-30 -151 --
Net loss
-220 -348 57 -127
Stock-based compensation
64 64 63 161
Depreciation and amortization
34 54 56 109
Non-cash operating lease expense
83 81 79 150
Interest expense on related party note payable
33 35 35 75
Change in inventory reserve
8 16 -26 55
Accounts receivable
68 -292 -86 43
Inventories
264 -71 -12 470
Prepaid expenses and other current assets
135 19 -107 146
Accounts payable
269 -97 -132 211
Accrued liabilities
413 -24 -199 124
Operating lease liabilities
-96 -93 -89 -172
Net cash provided by operating activities
121 32 49 -73
Purchases of property and equipment
23 3 3 37
Payments for patent licenses
8 2 --
Net cash used in investing activities
-31 -5 -3 -37
Payments on related party note payable
150 0 0 200
Net cash used in financing activities
-150 0 0 -200
Net (decrease) increase in cash
-60 27 46 -310
Cash, beginning of period
993 966 1,230 -
Cash, end of period
933 993 966 -
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Accrued liabilities$413K Accounts payable$269K Non-cash operating leaseexpense$83K Stock-based compensation$64K Depreciation andamortization$34K Interest expense onrelated party note...$33K Change in inventoryreserve$8K Net cash provided byoperating activities$121K Canceled cashflow$783K Net (decrease)increase in cash-$60K Canceled cashflow$121K Inventories$264K Net loss-$220K Prepaid expenses andother current assets$135K Operating leaseliabilities-$96K Accounts receivable$68K Product sales$2,315K Net cash used infinancing activities-$150K Net cash used ininvesting activities-$31K Loss from operations-$190K Total other expense,net-$30K Canceled cashflow$2,315K Payments on related partynote payable$150K Purchases of property andequipment$23K Payments for patentlicenses$8K Total operatingexpenses$2,505K General andadministrative$1,122K Cost of sales$954K Selling and marketing$273K Research and development$156K

International Stem Cell CORP (ISCO)

International Stem Cell CORP (ISCO)